stockportfolio.pro
Cytek Biosciences, Inc. Revenue 2020–2025
Cytek Biosciences, Inc. (CTKB) annual revenue by fiscal year, computed from SEC filings. Compound growth +209.5%/yr over 5 years.
| Fiscal year | Revenue | Change (YoY) |
|---|---|---|
| FY 2025 | $201.49M | +0.5% |
| FY 2024 | $200.45M | +3.7% |
| FY 2023 | $193.39M | +17.9% |
| FY 2022 | $164.04M | +7421.1% |
| FY 2021 | $2.18M | +207.2% |
| FY 2020 | $710,000 | — |
Source: Cytek Biosciences, Inc. SEC filings — income statement (10-K). Refreshed nightly.
See the full picture for Cytek Biosciences, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeCytek Biosciences, Inc. — frequently asked questions
What is Cytek Biosciences, Inc.'s revenue?
Cytek Biosciences, Inc. (CTKB) reported revenue of $201.49M for fiscal year 2025, per its SEC filings.
How has Cytek Biosciences, Inc.'s revenue changed over time?
Between fiscal 2020 and 2025, CTKB's revenue grew at roughly 209.5% per year (compound annual rate), from $710,000 to $201.49M.
Where does this data come from?
Figures are computed from Cytek Biosciences, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.